Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Racquet
It appears you cannot read. I didn’t say that Sue would be running BRH in a day to day job capacity did I ?
Tell me please what a NON executive can do and then please read again what I wrote.
Anyway, why are you here ? You post constantly trying to put off anyone invested or wanting to invest in BRH and always trying to plug your own share holding AVCT. Is it really worth all this time and effort being here talking nonsense ?
Rocquet
I think you may need to look again at the definition of a NON executive director.
She doesn’t need to be managing staff as part of the day to day business to be doing everything I already mentioned above...
Try Googling a bit more, you may learn something !!
This new appointment is very important indeed. We now have someone with a wealth of pharmaceutical experience and probably many good contacts in the industry.
Sue will probably be able to get the product news and information out to everyone in a more technical friendly way than is currently done so expect more informative announcements ahead.
Sue will also be there to keep the board on their toes and to put us investors along with the company finances in front of the personal needs from others (well I’m sure she will challenge any share negative financial transactions).
Overall, I see this as a good move by the company and definitely positive to move forward.
Rocquet,
All of TB’s companies have bagged multiples from their startups so I don’t think his faith is evaporating by making the usual regular sells making any difference to the company that’s left behind. Like I said, it’s not about Trevor, it’s about the belief in the fundamentals and products from the company you invest in.
I’m surprised at all the panic...
If you really believe in the fundamentals within Paraytec and like myself, you see a great product for the near future. If you do believe, then the SP means nothing but an opportunity to get in even cheaper than ever dreamed a month ago.
TB will always sell as you can see from his portfolio history but if you look beyond that and actually at the investment mainly (Paraytec and their amazing virus testing technology) .
Personally, I’m down enough (on paper) to buy a small house but I’m looking at the big picture down the line.
I’m a believer are you ?
James bought his 1,497,476 shares back around 1st/2nd Feb for around 36/37p probably when DC Thomson and co was selling a batch. He’s just an investor who I guess got worried so took his profit in case the price dropped any further. I don’t blame him when the SP is diving and at least he made a profit.
Sang,
What a load of drivel. Do you think a company must only own companies that only do exactly the same things that they do ?
You only need to look at a company like GSK to see that they own just about anything. Have a look here for reference.
https://www.gsk.com/media/3611/gsk-group-company-names-and-addresses.pdf
This was tweeted by Paraytec on 15th April:-
Paraytec is in discussion with analytical and life science instrumentation partners to further develop to the specifications required to meet the needs of biopharmaceutical company end-users and bring the miniaturized instrument to market.....
paraytec.com
It does seem that there are things going on in the background and I wouldn’t be surprised if Paraytec was sold on to one of the bigger pharmaceutical companies which would probably yield us a hefty dividend.
Rocquet,
You just commented that this isn’t like supporting a football team then continue to post exactly like you are supporting a team (mine is better than yours) !!
As I said before, Paraytec is not being marketed to compete with home Lateral flow tests, it cannot so these tests will still be required. It will however be a different ball game in the outside world where fast accurate testing is demanded. Most LFT have only been tested under a CT of 30 where a CT of 27 and below is likely to give a positive result. Try giving a LFT to someone asymptomatic or at the very early stages of infection, the CT will be much higher (around 37-40). The chances of detection could be reduced to less than 50 percent (toss a coin).
People who research companies they believe in are normally rewarded in the end. A long term holder doesn’t mean 1 month or less like some seem to think it is.
If you are prepared to wait, you will likely reap the rewards.
Sad,
I just answered this in the other post but I will answer it again here.
Paraytec’s test has not been built for home testing. It’s market would likely be where fast mass testing is required. This would be suited in hospitals, stadiums, exhibitions, museums, airports, hotels, cruise ships, etc... the list is endless. It would however replace LFT testing in all the above due to faster and more accurate testing.
Then we have the Matrix testing which combines samples from multiple people for simultaneous analysis, such that 20 parallel tests can yield individual results for up to one hundred people. This would be perfect for all of above.
As to the timing, it was known in the previous RNS about the 6 months to marketing, in fact it seems the PR team just copied and pasted that statement.
Bbq, I would be interested to know what stupid things I have written about here ??
If you cannot understand sarcasm to the original post then you may want to give up reading BB’s.
I have been involved with braveheart for the best part of a year now and I have researched as much information that is available with all their investments, so I think I know why I have invested and also made a pretty penny from these shares since investing.
I post where and when I see relevant so I don’t see why 3 posts would mean I have nothing to do with Braveheart, if I posted say 1000 times like many spammers/ramp/derampers, would that mean I know more about a company ??
Take a chill pill, wait for the RNS and if invested, hope you will be smiling tomorrow after it’s released.
Peace !!
Guys, you need to look logically at this.
TB needed money now, probably for Chamberlin PLC and as an investor himself with many hands in many pockets, he needs to juggle funds. Most CEO’s and other BODs don’t even own 1 percent of a company and Trev knows, due to insider knowledge, he can’t sell directly before any negative announcements or after any highly positive announcements. TB is not a one company man so he’s going to be buying and selling where he wants and with that knowledge of his history, it doesn’t worry me as much as if he was only in BRH.
Braveheart are purely an investment company and this is why they sold RMS when they did. It made a nice profit for the company which was then shared to the shareholders as a sizeable dividend.
It’s quite likely what will happen to Paraytec too once it’s built up and has a high value price tag.
Always remeber, BRH investments, they invest to make profit like we try to.
Personally, I believe that Paraytec have an edge on the current testing market and this patented technology is very likely to be a game changer in the next 6 months. I’m happy to stay invested and see it through. It’s a risk I see worth investing in and I believe anyone invested here will see great rewards to come....
That’s my take on it anyway. Dyor
The ex-dividend date, also known as the reinvestment date, is an investment term involving the timing of payment of dividends on stocks of corporations, income trusts, and other financial holdings, both publicly and privately held. The ex-date or ex-dividend date represents the date on or after which a security is traded without a previously declared dividend or distribution. Usually, but not necessarily, the opening price is the last closing price less the dividend amount.
A person purchasing a stock before its ex-dividend date, and holding the position before the market opens on the ex-dividend date, is entitled to the dividend. A person purchasing a stock on its ex-dividend date or after will not receive the current dividend payment.
To determine the ultimate eligibility of a dividend or distribution, the record date, not the ex-date, is relevant. Each shareholder entered in the shareholders' register at the record date is entitled to a dividend. Usually, the person owning the stock on close of business one business day before ex-date is also the person registered in the shareholders register on record date, because companies set the ex-date and record date of the dividend in line with the settlement cycle of the security. Most developed financial markets such as the USA, UK, Germany, France, etc. use a settlement cycle of T+2 for stocks.[4] As a result, companies in these markets set the ex-date one day before the record date of the dividend (example: ex-date Wednesday, record date Thursday: a security purchased on Tuesday will settle on Thursday; a person who bought the security on Tuesday bought one day before the ex-date and will be registered as shareholder on Thursday and hence be entitled to the dividend).
It’s certainly swimming against the current. I have to say this AML board is definitely one of the most informative that I have come across. Cheers
I don’t understand how the SP moves down so easily with just a few sells but then a lot of buys barely touch the sides !! This is one of the strangest share movements I have seen since watching for the last weeks. I did buy in during the dips so not too fussed but certainly confused.
Good News for Aviation
First UK airport Covid testing begins https://www.bbc.co.uk/news/business-54604100